Home›People›Jason Koh
JK

Jason Koh

Executive officer and director at Marrow Access Technologies.

ExecutiveDirector
Updated Nov 10, 2026·Latest SEC filing Apr 9, 2026·Suggest an edit

About Jason Koh

Jason Koh is an executive officer and director at Marrow Access Technologies.

Jason Koh first appears on SEC filings in 2018.

Experience

This experience comes from Jason Koh's profile and from SEC filings. For roles taken from filings, the years are when the filings name Jason Koh in the role, so the role may have started earlier or lasted longer.

Harvard Alumni Association Current
Board Member
2026 – Present
Endeavor Health Current
Physician Executive, Orthopaedic and Spine Institute
2025 – Present
Chicago Fire FC Current
Chief Medical Officer
2023 – Present
Marrow Access Technologies, Inc. Current
Chief Medical Officer (2016 – Present)
Director
2016 – Present · Eden Prairie, MN
Marrow access devices for surgeons treating patients with cartilage defects.
NorthShore University HealthSystem Current
Mark R. Neaman Family Chair of the Department of Orthopaedic Surgery
2009 – Present
The University of Chicago Current
Clinical Professor, Orthopaedic Surgery
2009 – Present
Aesculap Current
Scientific Advisory Board Member
2004 – Present
Northwestern University Current
Adjunct Professor of Biomedical Engineering
2000 – Present
HealthEngine LLC
Chairman, Clinical Advisory Board
2016 – 2018
Chicago Fire Soccer Club
Team Physician
2008 – 2015
The Joffrey Ballet
Medical Director
2000 – 2009
Chicago Cubs
Orthopaedic consultant
2000 – 2004
Cleveland Clinic
Orthopaedic Sports Medicine Fellow
1999 – 2000
Hospital for Special Surgery
Orthopaedic Surgery Resident
1995 – 1999
Massachusetts General Hospital
Surgical Resident
1994 – 1995
CNRS - Centre national de la recherche scientifique
Research Assistant
1990
National Institutes of Health
Research Assistant
1987 – 1988
Research Science Institute (RSI)
Student Researcher
1985

Key Colleagues at Startups

The people Jason Koh works with at each company, as listed on that company's latest Form D.

Marrow Access Technologies, Inc. · Form D, Apr 9, 2026
PV
DF
Dan Fisher
Director
JS
Joseph Saladino
CEO and director
KF
Kevin Foley
Director
JC
Jim Cloar
Director

Sources

  1. SECMarrow Access Technologies, Inc. Form D, filed Apr 9, 2026